Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats |
| |
| Authors: | Sicard Pierre Delemasure Stéphanie Korandji Claudia Segueira-Le Grand Anabelle Lauzier Benjamin Guilland Jean-Claude Duvillard Laurence Zeller Marianne Cottin Yves Vergely Catherine Rochette Luc |
| |
| Institution: |
a Laboratory of Experimental Cardiovascular Pathophysiology and Pharmacology, Dijon, France
b Flow Cytometry Center, University of Burgundy, IFR n°100, Faculties of Medicine and Pharmacy, Dijon, France
c Biochemistry LaboratoryCHU Bocage, Dijon, France
d Cardiology Service, CHU Bocage, Dijon, France |
| |
| Abstract: | Among their pleiotropic effects, statins exert antioxidant and anti-inflammatory properties. The aim of this study was to evaluate in normotensive (WKY) and in spontaneously hypertensive rats (SHR) the effect of rosuvastatin (ROSU) treatment on (1) plasma inflammation markers and endogenous NO synthase inhibitor (ADMA) levels, (2) reactive oxygen species (ROS) generated by circulating leukocytes and (3) vascular oxidative stress and tissue inflammation markers. Plasma cytokines were higher in SHR than in WKY, except for IL-4, which was lower in SHR than in WKY. SHR monocytes exhibited higher production of ROS than did WKY monocytes. In the experimental conditions, ROSU did not modify plasma cholesterol levels in SHR but attenuated the increase in systolic blood pressure. In SHR only, ROSU lessened pro-inflammatory cytokines and ADMA levels, increased IL-4 and reduced ROS production in circulating monocytes. These results demonstrate the beneficial effects of ROSU in SHR, independently of any lowering of cholesterol levels. |
| |
| Keywords: | Statins hypertension cytokines NAD(P)H oxidase leukocytes |
| 本文献已被 InformaWorld PubMed 等数据库收录！ |
|
